Item 16. Form 10-K Summary.

4K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary.

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		CVS HEALTH CORPORATION
Date:	February 9, 2022	By:	/s/ SHAWN M. GUERTIN
			Shawn M. Guertin
			Executive Vice President and Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title(s)	Date

/s/ FERNANDO AGUIRRE	Director	February 9, 2022
Fernando Aguirre

/s/ C. DAVID BROWN II	Director	February 9, 2022
C. David Brown II

/s/ JAMES D. CLARK	Senior Vice President - Controller and Chief	February 9, 2022
James D. Clark	Accounting Officer (Principal Accounting Officer)

/s/ ALECIA A. DECOUDREAUX	Director	February 9, 2022
Alecia A. DeCoudreaux

/s/ NANCY-ANN M. DEPARLE	Director	February 9, 2022
Nancy-Ann M. DeParle

/s/ DAVID W. DORMAN	Chair of the Board and Director	February 9, 2022
David W. Dorman

/s/ ROGER N. FARAH	Director	February 9, 2022
Roger N. Farah

/s/ ANNE M. FINUCANE	Director	February 9, 2022
Anne M. Finucane

/s/ SHAWN M. GUERTIN	Executive Vice President and Chief Financial	February 9, 2022
Shawn M. Guertin	Officer (Principal Financial Officer)

/s/ EDWARD J. LUDWIG	Director	February 9, 2022
Edward J. Ludwig

/s/ KAREN S. LYNCH	President and Chief Executive Officer	February 9, 2022
Karen S. Lynch	(Principal Executive Officer) and Director

/s/ JEAN-PIERRE MILLON	Director	February 9, 2022
Jean-Pierre Millon

/s/ MARY L. SCHAPIRO	Director	February 9, 2022
Mary L. Schapiro

/s/ WILLIAM C. WELDON	Director	February 9, 2022
William C. Weldon

/s/ TONY L. WHITE	Director	February 9, 2022
Tony L. White

Previous: Item 15. Exhibits, Financial Statement Schedules.